Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

19.42 -0.95 (-4.66%)
Official Closing Price Updated: 7:00 PM EDT, May 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,992,216
Open 20.11
Bid (Size) 19.32 (1)
Ask (Size) 19.60 (2)
Prev. Close 20.37
Today's Range 18.89 - 20.38
52wk Range 5.650 - 20.11
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hims & Hers Health Stock Soared This Week: Here's Why
The company is still riding momentum from its recent weight loss drug announcement. 
Via The Motley Fool
Looking At Hims & Hers Health's Recent Unusual Options Activity
Via Benzinga

Performance

YTD
+101.45%
+101.45%
1 Month
+57.37%
+57.37%
3 Month
+103.99%
+103.99%
6 Month
+136.25%
+136.25%
1 Year
+115.06%
+115.06%

More News

Read More
SPDR ETF Report For Thursday, May 30
Via Talk Markets
Topics ETFs
Call Option Volumes Spiked For These 3 Stocks
Via MarketBeat
SPDR ETF Report For Wednesday, May 29
Via Talk Markets
Topics ETFs
Smart Money Is Betting Big In HIMS Options
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
Navigating 10 Analyst Ratings For Hims & Hers Health
Via Benzinga
SPDR ETF Report For Tuesday, May 28
Via Talk Markets
Topics ETFs
A New Name in Weight Loss Drugs
Via The Motley Fool
LifeMD Can Surge on Its GLP-1 Offerings
Via MarketBeat
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
Via The Motley Fool
Hims & Hers Is Changing the Game
Via The Motley Fool
The Ultimate Growth Stock to Buy With $20 Right Now
Via The Motley Fool
7 Stocks to Dominate in the Next Economic Upturn
Via InvestorPlace
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
Via InvestorPlace
The Growth Stock Shuffle: 2 to Ditch and 1 to Own
Via InvestorPlace
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Via Benzinga
Topics ETFs
Meme Stocks GameStop, AMC Fade In Interest After Roaring Kitty Exit: Here's What WallStreetBets Is Eyeing Next
Via Benzinga
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
Via InvestorPlace
Tech Surge Boosts Nasdaq To Record Highs
Via Talk Markets
Topics Stocks
Exposures US Equities
Stocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets Monday?
Via Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.